Neoplasms

Respiratory Tract (Lung and Bronchial) Diseases

All Conditions

Substance Related Disorders

Behaviors and Mental Disorders

Lung Neoplasms

Alcoholism

Tobacco Use Disorder

Alcohol Drinking

Head and Neck Neoplasms

Respiratory Tract Neoplasms

Thoracic Neoplasms

Lung Diseases

Respiratory Tract Diseases

All Drugs and Chemicals

Anti-Infective Agents

Central Nervous System Depressants

Nicotine

Carbon Monoxide

Ethanol

patient with a first head and neck cancer or first lung cancer

* Socio-economic conditions and general features: educational level, professional status...
* Assessment of current and past use of tobacco: current smoking status reported by the patient; in lifelong non-smokers: previous history of passive smoking reported by the patient; breath carbon monoxide level; in past smokers: age of first cigarette, total reported duration of active smoking, breath carbon monoxide level...
* in current smokers: age of first tobacco use, total reported duration of active smoking; Fagerström Nicotine Dependence Test...
* Assessment of the current and past uses of alcohol: previous-year assessment using the CAGE questionnaire and the AUDIT Test; average weekly alcohol consumption over the last 12 months...
* Assessment of current use of cannabis using the Cannabis Abuse Screening Test
* Psychiatric assessment using the MINI 5.0

physician assessment

Corinne VANNIMENUS, MD

This is an multicenter study for preventive and therapeutic strategies for patients with head and neck cancer

Continuing the chronic intoxication by either tobacco or alcohol after the initial diagnosis of a first lung or head and neck cancer significantly improves the risk of experiencing a second cancer, and largely affects the long term survival. Addiction intervention programs should be personalized according to the patient's profile, with the aim to develop more sustained intervention and monitoring in patients identified at higher risk of not spontaneously stopping harmful substance use. As of today, the trajectories of smoking and drinking habits and the risk factors for persisting smoking or drinking habits have been insufficiently explored among patients with a first lung or head and neck cancer.

The ALTAK study aims to depict the rate of tobacco smokers 12 months after the initial diagnosis of a first lung or head and neck cancer. The secondary objectives of the study are:

* to depict the rate of alcohol users 12 months after the initial diagnosis of a H\&N cancer
* to depict the rate of tobacco smokers at cancer diagnosis
* to depict the rate of alcohol users at cancer diagnosis
* to determine the social, motivational, psychiatric, tobacco-related, alcohol-related, and cannabis-related features associated with stopping tobacco in the year following the diagnosis of a first TARC.
* to determine the social, psychiatric, tobacco-related, alcohol-related, and cannabis-related features associated with stopping alcohol drinking in the year following the diagnosis of a first H\&N cancer

Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer

Prevalence and Risk Factors for Persistent Tobacco or Alcohol Use Over the First Year of a First Lung or Head and Neck Cancer

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer	NCT01647425	Head and Neck C... Lung Cancer	physician asses...	18 Years -	Centre Oscar Lambret
Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer	NCT01647425	Head and Neck C... Lung Cancer	physician asses...	18 Years -	Centre Oscar Lambret

Spots Global Cancer Trial Database for physician assessment